SpliSense

About SpliSense

SpliSense is a biotechnology company developing RNA-based therapies using antisense oligonucleotides to restore or modify protein function for untreatable pulmonary diseases. The company focuses on conditions such as cystic fibrosis and IPF, as well as muco-obstructive pulmonary diseases, leveraging antisense approaches to address root causes at the molecular level. Its platform and research aim to enable targeted modulation of gene expression in the respiratory system. Headquartered with activities centered on pulmonary therapeutics, SpliSense pursues translational programs that target lung diseases through RNA-based interventions.